For instance, in June 2026, Novo Nordisk and Sumitomo Pharma, two major global pharmaceutical companies, announced that they have finalized a co-promotion agreement for Ozempic (Semaglutide SC injection) in Japan
Ravid successfully completed his residency in Family Medicine at the Louisiana State University School of Medicine, New Orleans
Rybelsus is a GLP-1 receptor agonist that is used in type 2 diabetes care and sometimes discussed within broader weight-management conversations depending on the clinical plan
Potency loss may occur without any visible change, meaning the solution could appear intact whilst delivering a sub-therapeutic or unpredictable dose
For the second mouse study, antibody treatments were given subcutaneously on days 0, 4, 7, 14, and 21 of the study